DN Decision Briefs / Platform evidence
Collateral, shared margin and fee treatment depend on account mode and market. This brief separates unified accounts, portfolio margin and standard mode instead of treating every Hyperliquid balance alike.
What Matters
Provider-documentation review focused on perpetual trading. Not an exhaustive product inventory, live execution test, security audit or individual eligibility assessment.
A balance visible in an account is not a universal margin allowance. Identify the account mode, DEX and collateral token before interpreting available capital.
DN Evidence Block
Unified mode shares an asset balance across spot and cross-margin positions using that asset. Standard mode separates spot, perps and DEX balances.
Why it matters: Read balances in the context of account mode; a cross-margin boundary is not identical across modes.
Hyperliquid account abstraction modesThe reviewed mode guide lists HYPE, BTC, USDC and USDT as eligible portfolio assets. Portfolio documentation imposes entry requirements, haircuts and supply/borrow caps.
Why it matters: Eligibility is conditional. Check current caps and margin recognition rather than counting the full market value of each holding.
Hyperliquid account abstraction modesHyperliquid portfolio marginFees vary with rolling weighted volume and other adjustments. The guide distinguishes spot and perps, staking tiers, HIP-3 deployer fees and growth-mode treatment.
Why it matters: Inspect the actual market and route. A base tier is not a universal all-in rate.
Hyperliquid feesPerpetual funding is exchanged hourly between sides. Portfolio borrowing can also accrue interest.
Why it matters: Funding, borrow interest and trade fees are separate components. A funding receipt does not prove the overall position is profitable.
Hyperliquid fundingHyperliquid portfolio marginThe general liquidation guide uses mark-price and maintenance-margin rules. Portfolio margin has an account-level calculation and does not promise a fixed order of liquidation across exposures.
Why it matters: Use the rules for the selected mode. DN has not tested liquidation or stop-loss outcomes.
Hyperliquid liquidationsHyperliquid portfolio marginThis review does not establish personal eligibility, deployed permission scope or end-to-end availability.
Why it matters: Verify current terms and signing requests separately; this is research, not an instruction to connect or trade.
Evidence boundary
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
The receipt preserves the provider sources and research gaps at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
Change record
Initial documentation brief. Account-specific conditions and evidence limits are preserved in this version.
Review triggers: Changed official product, fee or margin documentation; A substantiated correction; The 14-day editorial review deadline. No automated provider surveillance runs for this brief.
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN may receive compensation through commercial links elsewhere on the site. This brief contains no trading CTA or payout-based ranking. A documentation review does not establish current operational status or user eligibility.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.
